BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1054@pharmaconomics
DTSTAMP:20260707T033942Z
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260225
SUMMARY:LRMR AdCom — nomlabofusp
DESCRIPTION:An FDA advisory committee reviews nomlabofusp for Friedreich's ataxia around Feb 24\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1374690/000119312526115119/lrmr-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/1054
URL:https://pharmaconomics.com/e/1054
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:LRMR catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR